Combined newborn screening for succinylacetone, amino acids, and acylcarnitines in dried blood spots.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Clinical Chemistry

• Publication date

  2008-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1373/clinchem.2007.101949PMID 18281422
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Reduction of the false-positive rate in newborn screening by implementation of MS/MS-based second-tier tests: The Mayo Clinic experience (2004–2007)

  2007cited by this paper
• Tandem mass spectrometric determination of succinylacetone in dried blood spots enables presymptomatic detection in a case of hepatorenal tyrosinaemia

  2007cited by this paper
• The tandem mass spectrometry newborn screening experience in North Carolina: 1997–2005

  2006cited by this paper
• Newborn screening for hepatorenal tyrosinemia: Tandem mass spectrometric quantification of succinylacetone.

  2006cited by this paper
• Quantitative determination of succinylacetone in dried blood spots for newborn screening of tyrosinemia type I.

  2006influential reference
• Newborn Screening: Toward a Uniform Screening Panel and System—Executive Summary

  2006cited by this paper
• Making the case for objective performance metrics in newborn screening by tandem mass spectrometry.

  2006cited by this paper
• Newborn screening: toward a uniform screening panel and system.

  2006cited by this paper
• Two Japanese brothers with hereditary γ-glutamyl transpeptidase deficiency

  2005cited by this paper
• Two Japanese brothers with hereditary gamma-glutamyl transpeptidase deficiency.

  2005cited by this paper
• A biochemical perspective on the use of tandem mass spectrometry for newborn screening and clinical testing.

  2005cited by this paper
• Newborn screening for hepatorenal tyrosinemia by tandem mass spectrometry: analysis of succinylacetone extracted from dried blood spots.

  2004cited by this paper
• Use of tandem mass spectrometry for multianalyte screening of dried blood specimens from newborns.

  2003cited by this paper
• Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death.

  2001cited by this paper
• Rapid diagnosis of methylmalonic and propionic acidemias: quantitative tandem mass spectrometric analysis of propionylcarnitine in filter-paper blood specimens obtained from newborns.

  2001cited by this paper
• Spectrophotometric microassay for delta-aminolevulinate dehydratase in dried-blood spots as confirmation for hereditary tyrosinemia type I.

  2001cited by this paper
• The Metabolic and Molecular Bases of Inherited Disease

  2001cited by this paper
• Nontransplant treatment of tyrosinemia.

  2000cited by this paper
• Detection of succinylacetone and the use of its measurement in mass screening for hereditary tyrosinemia.

  1982cited by this paper

• Matrix effects influence biochemical signatures and metabolite quantification in dried blood spots

  2025influential citation
• Advancing Clinical Liquid Chromatography-Mass Spectrometry Analysis: Rational Design and Optimization of Derivatization Techniques for Enhanced Sensitivity and Throughput

  2025cites this paper
• Effect of newborn genomic screening for lysosomal storage disorders: a cohort study in China

  2025cites this paper
• Integrating newborn genetic screening with traditional screening to improve newborn screening

  2025cites this paper
• Evaluation of Neonatal Screening Programs for Tyrosinemia Type 1 Worldwide

  2024influential citation
• Diagnosis, treatment, management and monitoring of patients with tyrosinaemia type 1: Consensus group recommendations from the German‐speaking countries

  2024cites this paper
• Decoding hepatorenal tyrosinemia type 1: Unraveling the impact of early detection, NTBC, and the role of liver transplantation.

  2024cites this paper
• Evaluation of different isotope dilution mass spectrometry strategies for the characterization of naturally abundant and isotopically labelled peptide standards

  2024cites this paper
• New Cases of Maleylacetoacetate Isomerase Deficiency with Detection by Newborn Screening and Natural History over 32 Years: Experience from a German Newborn Screening Center

  2024cites this paper
• Characterizing the mechanism of action for mRNA therapeutics for the treatment of propionic acidemia, methylmalonic acidemia, and phenylketonuria

  2024cites this paper
• Maleic acid is a biomarker for maleylacetoacetate isomerase deficiency; implications for newborn screening of tyrosinemia type 1

  2023cites this paper
• Development of a Universal Second-Tier Newborn Screening LC–MS/MS Method for Amino Acids, Lysophosphatidylcholines, and Organic Acids

  2023cites this paper
• High-Throughput Analysis of Underivatized Amino Acids and Acylcarnitines in Infant Serum: A Micromethod Based on Stable Isotope Dilution Targeted HILIC-ESI-MS/MS.

  2023cites this paper
• Metabolomics of a neonatal cohort from the Alliance for Maternal and Newborn Health Improvement biorepository: Effect of preanalytical variables on reference intervals

  2023cites this paper
• A False-Negative Newborn Screen for Tyrosinemia Type 1—Need for Re-Evaluation of Newborn Screening with Succinylacetone

  2023cites this paper
• Sources and Sinks of Serine in Nutrition, Health, and Disease

  2023cites this paper
• Molecularly imprinted nanoparticles doped graphene oxide based electrochemical platform for highly sensitive and selective detection of L-tyrosine.

  2023cites this paper
• Chromatomass-Spectrometric Method for the Quantitative Determination of Amino- and Carboxylic Acids in Biological Samples

  2022cites this paper
• Determination of 3-monoiodotyrosine and 3,5-diiodotyrosine in newborn urine and dried urine spots by isotope dilution tandem mass spectrometry.

  2022cites this paper
• Clinical experience with hepatorenal tyrosinemia from a single Egyptian center

  2022cites this paper
• Combined genetic screening and traditional biochemical screening to optimize newborn screening systems.

  2022cites this paper
• Combining data acquisition modes in liquid-chromatography–tandem mass spectrometry for comprehensive determination of acylcarnitines in human serum

  2022cites this paper
• Inherited Metabolic Diseases

  2021cites this paper
• Arginase-1 deficiency in neural cells does not contribute to neurodevelopment or functional outcomes after sciatic nerve injury.

  2021cites this paper
• Genetically blocking HPD via CRISPR-Cas9 protects against lethal liver injury in a pig model of tyrosinemia type I

  2021cites this paper
• Long-term safety and outcomes in hereditary tyrosinaemia type 1 with nitisinone treatment: a 15-year non-interventional, multicentre study.

  2021cites this paper
• Limited Expansion of Human Hepatocytes in FAH/RAG2-Deficient Swine

  2021cites this paper
• Development of Flow Injection Analysis Method for the Second-Tier Estimation of Succinylacetone in Dried Blood Spot of Newborn Screening

  2021cites this paper
• The Importance of Succinylacetone: Tyrosinemia Type I Presenting with Hyperinsulinism and Multiorgan Failure Following Normal Newborn Screening

  2020cites this paper
• Application of Derivatization in Fatty Acids and Fatty Acyls Detection: Mass Spectrometry‐Based Targeted Lipidomics

  2020cites this paper
• Novel biomarkers and age-related metabolite correlations in plasma and dried blood spots from patients with succinic semialdehyde dehydrogenase deficiency

  2020cites this paper
• Dual mRNA therapy restores metabolic function in long-term studies in mice with propionic acidemia

  2020cites this paper
• The Combined Impact of CLIR Post-Analytical Tools and Second Tier Testing on the Performance of Newborn Screening for Disorders of Propionate, Methionine, and Cobalamin Metabolism

  2020cites this paper
• Laboratory monitoring of patients with hereditary tyrosinemia type I.

  2020cites this paper
• Identifying and overcoming barriers to harmonize newborn screening programs through consensus strategies

  2020cites this paper
• A highly multiplexed biochemical assay for analytes in dried blood spots: application to newborn screening and diagnosis of lysosomal storage disorders and other inborn errors of metabolism

  2020cites this paper
• Longitudinal metabolomics in dried bloodspots yields profiles informing newborn screening for succinic semialdehyde dehydrogenase deficiency

  2020cites this paper
• Post-mortem tissue analyses in a patient with succinic semialdehyde dehydrogenase deficiency (SSADHD). I. Metabolomic outcomes

  2020cites this paper
• Isotope Labeling Strategies for Acylcarnitines Profile in Biological Samples by Liquid Chromatography-Mass Spectrometry.

  2019cites this paper
• Function, Detection and Alteration of Acylcarnitine Metabolism in Hepatocellular Carcinoma

  2019cites this paper
• Diagnosis and the importance of early treatment of tyrosinemia type 1: A case report.

  2019cites this paper
• Emerging trends in paper spray mass spectrometry: Microsampling, storage, direct analysis, and applications.

  2019cites this paper
• The significant role of carnitine and fatty acids during pregnancy, lactation and perinatal period. Nutritional support in specific groups of pregnant women.

  2019cites this paper
• Temporal metabolomics in dried bloodspots suggests multipathway disruptions in aldh5a1-/- mice, a model of succinic semialdehyde dehydrogenase deficiency.

  2019cites this paper
• Roles of Arginase-1 in Neural Cells

  2019cites this paper
• Mathematical models of amino acid panel for assisting diagnosis of children acute leukemia

  2019cites this paper
• Genotype, phenotype and in silico pathogenicity analysis of HEXB mutations: Panel based sequencing for differential diagnosis of gangliosidosis.

  2018cites this paper
• JIMD Reports, Volume 38

  2018cites this paper
• Combining newborn metabolic and DNA analysis for second-tier testing of methylmalonic acidemia

  2018cites this paper
• Chapter 6 – Newborn screening

  2017cites this paper
• Diagnosis and treatment of tyrosinemia type I: a US and Canadian consensus group review and recommendations

  2017cites this paper
• NEWBORN SCREENING SECOND TIER TESTS ( 2 TT ) IN DRIED

  2017cites this paper
• Analysis of amino acids and acyl carnitine profiles in low birth weight, preterm, and small for gestational age neonates

  2017cites this paper
• Advances in Clinical Mass Spectrometry.

  2017cites this paper
• Newborn screening for Tyrosinemia type 1 using succinylacetone – a systematic review of test accuracy

  2017influential citation
• Diet-resistant obesity is characterized by a distinct plasma proteomic signature and impaired muscle fiber metabolism

  2017cites this paper
• Open-Label Single-Sequence Crossover Study Evaluating Pharmacokinetics, Efficacy, and Safety of Once-Daily Dosing of Nitisinone in Patients with Hereditary Tyrosinemia Type 1

  2017cites this paper
• Moonlighting newborn screening markers: the incidental discovery of a second-tier test for Pompe disease

  2017cites this paper
• Chronic Phenotype Characterization of a Large-Animal Model of Hereditary Tyrosinemia Type 1.

  2017cites this paper
• Comparison of a full systematic review versus rapid review approaches to assess a newborn screening test for tyrosinemia type 1

  2017cites this paper
• Comparison of a full systematic review versus a rapid review approaches to assess a newborn screening test for tyrosinemia type 1

  2017cites this paper
• Liver-specific knockout of arginase-1 leads to a profound phenotype similar to inducible whole body arginase-1 deficiency

  2016cites this paper
• Validation of amino-acids measurement in dried blood spot by FIA-MS/MS for PKU management.

  2016cites this paper
• Fluorescent derivatization combined with aqueous solvent-based dispersive liquid-liquid microextraction for determination of butyrobetaine, l-carnitine and acetyl-l-carnitine in human plasma.

  2016cites this paper
• A Rapid Screening Test on Dried Blood for the Neonatal Diagnosis of Tyrosinemia Type I

  2016cites this paper
• Expanded newborn screening by mass spectrometry: New tests, future perspectives.

  2016cites this paper
• The use of mass spectrometry to analyze dried blood spots.

  2016cites this paper
• Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma

  2016cites this paper
• Undernutrition during pregnancy in mice leads to dysfunctional cardiac muscle respiration in adult offspring

  2015cites this paper
• Long-Term Sex-Biased Correction of Circulating Propionic Acidemia Disease Markers by Adeno-Associated Virus Vectors

  2015cites this paper
• Outcome of children with hereditary tyrosinaemia following newborn screening

  2015cites this paper
• Neue Zielerkrankungen im Neugeborenenscreening

  2015cites this paper
• Fumarylacetoacetate hydrolase deficient pigs are a novel large animal model of metabolic liver disease.

  2014cites this paper
• Mass spectrometry in clinical chemistry: the case of newborn screening.

  2014cites this paper
• Tyrosinemia type 1: an overview of nursing care.

  2014cites this paper
• Effects of Adeno-Associated Virus Serotype and Tissue-Specific Expression on Circulating Biomarkers of Propionic Acidemia

  2014cites this paper
• Derivatization Techniques in Dried Blood Spot Analysis

  2014cites this paper
• Applications of Dried Blood Spots in Newborn and Metabolic Screening

  2014cites this paper
• Neu-Laxova syndrome, an inborn error of serine metabolism, is caused by mutations in PHGDH.

  2014cites this paper
• Dried blood spots: concepts, present status, and future perspectives in bioanalysis.

  2014cites this paper
• Mass spectrometry in clinical chemistry: the case of newborn screening.

  2014cites this paper
• Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs.

  2014cites this paper
• Newborn Screening by Tandem Mass Spectrometry and Molecular Confirmation

  2014cites this paper
• LC–MS/MS in the routine clinical laboratory: has its time come?

  2014cites this paper
• Association of Amino Acids with Common Complications of Prematurity

  2013cites this paper
• Amino acid analysis of dried blood spots for diagnosis of phenylketonuria using capillary electrophoresis-mass spectrometry equipped with a sheathless electrospray ionization interface

  2013cites this paper
• Generation of a hypomorphic model of propionic acidemia amenable to gene therapy testing.

  2013cites this paper
• Newborn screening for hepatorenal tyrosinemia-I by tandem mass spectrometry using pooled samples: a four-year summary by the New England newborn screening program.

  2013cites this paper
• Clinical and environmental influences on metabolic biomarkers collected for newborn screening.

  2013cites this paper
• Determination of gamma-hydroxybutyric acid in microvolumes of biological fluids following direct derivatization and gas chromatography mass spectrometry

  2013cites this paper
• Newborn screening for lysosomal storage disorders and other neuronopathic conditions.

  2013cites this paper
• Investigating the genetics Of thyroid stimulating hormone in newborns

  2013cites this paper
• A new approach to dried blood spot analysis for newborn screening using high resolution liquid chromatography tandem mass spectrometry

  2012cites this paper
• Isotope dilution direct injection mass spectrometry method for determination of four tyrosine kinase inhibitors in human plasma.

  2012cites this paper
• 3-hydroxyacyl-coenzyme a dehydrogenase deficiency: identification of a new mutation causing hyperinsulinemic hypoketotic hypoglycemia, altered organic acids and acylcarnitines concentrations.

  2012cites this paper
• The Proline/Citrulline Ratio as a Biomarker for OAT Deficiency in Early Infancy.

  2012cites this paper
• The heritability of metabolic profiles in newborn twins

  2012cites this paper
• Targeted metabolomic analysis of plasma samples for the diagnosis of inherited metabolic disorders.

  2012cites this paper
• [Clinical follow up of Chilean patients with tyrosinemia type 1 treated with 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-ciclohexanedione (NTBC)].

  2012cites this paper
• Dried blood spot analysis by digital microfluidics coupled to nanoelectrospray ionization mass spectrometry.

  2012cites this paper